Open Access iconOpen Access

ARTICLE

Long noncoding RNA PPP1R14B-AS1 imitates microRNA-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1

LIMIN ZHOU1, LIANBO ZHANG2, XIN GUAN3, YI DONG1, TAO LIU1,*

1 Department of Second Breast Surgery, Jilin Cancer Hospital, Jilin, 130012, China
2 Medical Insurance Guarantee Office, Jilin Cancer Hospital, Jilin, 130012, China
3 Department of Breast Surgery, The First Hospital of Jilin University, Jilin, 130061, China

* Corresponding Author: TAO LIU. Email: email

Oncology Research 2021, 29(4), 251-262. https://doi.org/10.32604/or.2022.03582

Abstract

Long noncoding RNA PPP1R14B antisense RNA 1 (PPP1R14B-AS1) has emerged as a critical modulator of liver cancer and lung adenocarcinoma progression. However, the functional importance and biological relevance of PPP1R14B-AS1 in breast cancer remain unclear. Therefore, this study was designed to detect PPP1R14B-AS1 levels in breast cancer cells using qRT–PCR and elucidate the influence of PPP1R14B-AS1 on aggressive phenotypes. Furthermore, molecular events mediating the action of PPP1R14B-AS1 were characterized in detail. Functional experiments addressed the impacts of PPP1R14B-AS1 knockdown on breast cancer cells. In this study, PPP1R14B-AS1 was found to be overexpressed in breast cancer, exhibiting a close correlation with poor patient prognosis. Results also showed that breast cancer cell proliferation and motility were suppressed when PPP1R14B-AS1 was silenced. Mechanistically, PPP1R14B-AS1 acted as a competing endogenous RNA for microRNA-134-3p (miR-134-3p) in breast cancer cells. PPP1R14B-AS1 also increased LIM and SH3 protein 1 (LASP1) levels by imitating miR-134-3p in breast cancer cells. Rescue experiments further corroborated that the knockdown of miR-134-3p or an increase in LASP1 restored the aggressive malignant characteristics of breast cancer cells that were weakened by PPP1R14B-AS1 depletion. In summary, PPP1R14B-AS1 facilitated the oncogenicity of breast cancer cells by controlling the miR-134-3p/LASP1 axis. We believe that our findings may contribute to the development of precision therapy techniques in the field of breast cancer treatment.

Keywords


Cite This Article

APA Style
ZHOU, L., ZHANG, L., GUAN, X., DONG, Y., LIU, T. (2021). Long noncoding RNA PPP1R14B-AS1 imitates microrna-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1. Oncology Research, 29(4), 251-262. https://doi.org/10.32604/or.2022.03582
Vancouver Style
ZHOU L, ZHANG L, GUAN X, DONG Y, LIU T. Long noncoding RNA PPP1R14B-AS1 imitates microrna-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1. Oncol Res. 2021;29(4):251-262 https://doi.org/10.32604/or.2022.03582
IEEE Style
L. ZHOU, L. ZHANG, X. GUAN, Y. DONG, and T. LIU "Long noncoding RNA PPP1R14B-AS1 imitates microRNA-134-3p to facilitate breast cancer progression by upregulating LIM and SH3 protein 1," Oncol. Res., vol. 29, no. 4, pp. 251-262. 2021. https://doi.org/10.32604/or.2022.03582



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1194

    View

  • 594

    Download

  • 0

    Like

Share Link